Specify Company / Ticker to Get the Summary
Dividend History AVDL
Dividend Analytics AVDL
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Avadel Pharmaceuticals PLC
AVDLAvadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland. Address: 10 Earlsfort Terrace, Dublin, Ireland, D02 T380
Analytics
WallStreet Target Price
16.57 USDP/E Ratio
–Dividend Yield
–Financials AVDL
Results | 2019 | Dynamics |